The enzyme cost of a flux
Economic Principles in Cell Biology · Ch. 6 · 10.5281/zenodo.8154381
FBA treated a flux as free once it balanced. It isn't. Every reaction needs enzyme to carry it, and enzyme is protein drawn from a finite budget. FBA asks what flux is possible. Ask the dual question instead: what does this flux cost in protein? The answer explains why cells reject the highest-yield pathway.
Flux has a price in protein
To carry flux v through a reaction, you need enzyme in proportion. The faster you push, the more copies you must build. The cost of a step is its flux divided by how fast one enzyme works, v / kcat. A pathway's total protein cost is the sum over its steps, and the slowest enzyme dominates the bill.
Thermodynamics raises the price
Thermodynamics adds a second, subtler cost. A reaction run far from equilibrium goes almost entirely forward. Run it close to equilibrium and the backward reaction nearly cancels the forward one, so you must build extra enzyme just to net the same flux. The penalty is a factor 1 / (1 − eΔG/RT): negligible when ΔG is strongly negative, and exploding as ΔG approaches zero. Thermodynamic driving force and protein cost are two views of the same thing.
Now Chapter 5's puzzle dissolves. The highest-yield pathway may thread slow enzymes or near-equilibrium steps, making it ruinously expensive in protein. A lower-yield route that runs on cheap, fast, strongly-driven enzymes can leave more of the budget for growth. Yield-optimal and growth-optimal part ways precisely because flux costs protein. Enzyme cost minimization is the tool that picks the winner: choosing metabolite concentrations and pathways to carry a demanded flux for the least protein.
Neighbors
Related chapters
- 🦠 Ch.5 Optimizing fluxes — the yield-vs-growth puzzle this chapter answers
- 🦠 Ch.8 Microeconomics — cost and benefit made into a full economic choice
- 🦠 Ch.3 Metabolism — where the ΔG that sets this cost comes from
Foundations
Adaptation notes
The source chapter builds enzyme cost minimization carefully, including how metabolite concentrations are chosen to minimize protein demand and how alternative pathways compare. We take the two costs that drive the result, turnover and thermodynamic reversibility, and make each runnable on its own. The full optimization over metabolite levels, and the formal pathway comparison, are in the source and its companion paper.